1. Home
  2. RGNT vs BFRI Comparison

RGNT vs BFRI Comparison

Compare RGNT & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

HOLD

Current Price

$0.72

Market Cap

14.3M

Sector

Health Care

ML Signal

HOLD

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$0.54

Market Cap

12.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGNT
BFRI
Founded
2004
1997
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.3M
12.2M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
RGNT
BFRI
Price
$0.72
$0.54
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $6.00
AVG Volume (30 Days)
43.5K
★ 185.0K
Earning Date
09-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 67.70
EPS
★ N/A
N/A
Revenue
N/A
★ $41,705,000.00
Revenue This Year
N/A
$12.70
Revenue Next Year
N/A
$13.40
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 11.75
52 Week Low
$0.81
$0.54
52 Week High
$15.50
$1.66

Technical Indicators

Market Signals
Indicator
RGNT
BFRI
Relative Strength Index (RSI) 21.62 27.34
Support Level N/A N/A
Resistance Level $2.52 $0.96
Average True Range (ATR) 0.15 0.09
MACD -0.03 -0.03
Stochastic Oscillator 3.85 0.33

Price Performance

Historical Comparison
RGNT
BFRI

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Share on Social Networks: